Role of DNA ploidy analysis in endometrial adenocarcinoma

Annals of Diagnostic Pathology

Volumn 5, Issue 5, 2001, Pages 267-273

  Jhala, Darshana N ^a   Atkinson, Barbara F ^a   Balsara, Gulnar R ^a   Hernandez, Enrique ^a   Jhala, Nirag C ^a,b,c  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF KANSAS   (United States)

^c TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

DNA ploidy; Endometrial adenocarcinoma; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; ASCITES FLUID CYTOLOGY; CANCER CLASSIFICATION; CANCER GRADING; CANCER STAGING; DIPLOIDY; ENDOMETRIUM CARCINOMA; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; REPRODUCIBILITY; TUMOR DIFFERENTIATION;

EID: 0034798580     PISSN: 10929134     EISSN: None     Source Type: Journal    
DOI: 10.1053/adpa.2001.27913     Document Type: Article

References (30)

1. Cancer statistics, 2001
2. Prognostic factors in early carcinoma of the endometrium
3. Risk factors and recurrent patterns in stage I endometrial adenocarcinoma
4. Results of therapy, analysis of failures, and prognostic factors for clinical and pathologic stage III adenocarcinoma of the endometrium
5. Evaluation of unfavorable histologic subtypes in endometrial adenocarcinoma
6. Peritoneal cytology in patients with endometrial adenocarcinoma
7. The importance of peritoneal cytology in endometrial carcinoma
8. Peritoneal cytology endometrial adenocarcinoma
9. DNA ploidy, morphometry, and nuclear grade as prognostic factors in endometrial carcinoma
10. DNA ploidy in endometrial carcinoma: Major objective prognostic factor
11. Carcinoma of the endometrium: Do the nuclear grade and ploidy provide more prognostic information than do the FIGO and WHO classifications?
12. Predictive value of cell kinetics in endometrial adenocarcinoma
13. Preoperative evaluation of tumor ploidy in endometrial carcinoma: An accurate tool to identify patients at risk for extrauterine disease and recurrence
14. Evaluation of DNA ploidy in endometrial cancer
15. Flow cytometric DNA analysis of stage I endometrial carcinoma
16. Changes in gynecologic cancer staging by the international federation of gynecology and obstetrics
17. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry
18. A detergent trypsin method for the preparation of nuclei for flow cytometric DNA analysis
19. Analysis of the relationships of the ploidy and cell cycle kinetics to differentiation and the female sex steroid hormone receptors in adenocarcinoma of the endometrium
20. Flow cytometric deoxyribonucleic acid index: A prognostic factor in endometrial carcinoma
21. Flow cytometric DNA and clinical parameters in prediction of prognosis in stage I-II endometrial carcinoma
22. Prognostic significance of flow cytometric and clinical variables in endometrial adenocarcinoma stages I-II
23. Analysis of the prognostic factors of endometrial carcinoma: A retrospective study of 144 patients
24. Prognostic significance of proliferation in endometrial adenocarcinomas: A multivariate analysis of clinical and flow cytometric variables
25. DNA ploidy, cell proliferation and steroid hormone receptors in endometrial hyperplasia and early adenocarcinoma
26. Aggressive stage I grade I endometrial carcinoma
27. Ploidy disturbances as an early indicator of intrinsic malignancy in endometrial carcinoma
28. Flow cytometry analysis of endometrial hyperplasia and carcinoma
29. Flow cytometric measurements of DNA index and S-phase on paraffin embedded early stage endometrial cancer: An important prognostic indicator
30. Evaluation of the reproducibility of the revised international federation of gynecology and obstetrics grading system of endometrial cancers with special emphasis on nuclear grading